publication venue for

• An FDG-PET-Based Machine Learning Framework to Support Neurologic Decision-Making in Alzheimer Disease and Related Disorders 2025
• Core Clinical Features Associated With Survival in Patients With Dementia With Lewy Bodies 2025
• Gene-Specific Effects on Brain Volume and Cognition of TMEM106B in Frontotemporal Lobar Degeneration 2024
• Phenoconversion in Women and Men With Isolated REM Sleep Behavior Disorder 2024
• Characteristics of REM Sleep Behavior Disorder Affect the Risk of Developing an Overt Synucleinopathy 2023
• Clinical Predictors of Survival in Probable Dementia with Lewy Bodies 2023
• Cross-sectional Associations of β-Amyloid, Tau, and Cerebrovascular Biomarkers With Neurodegeneration in Probable Dementia With Lewy Bodies 2023
• Impact of Bilingualism on the Cognitive Outcomes in Stroke Survivors: A Systematic Review 2023
• Longitudinal free-water changes in dementia with Lewy bodies 2023
• Semantic Variant Primary Progressive Aphasia Associated with the C9orf72 Hexanucleotide Expansion - A Longitudinal Case Report 2023
• Upper Cervical Cord Volume and Its Association with Brain Metrics in MS 2023
• White Matter Degeneration Pathways Associated With Tau Deposition in Alzheimer Disease 2023
• β-Amyloid Load on PET Along the Continuum of Dementia With Lewy Bodies 2023
• Cerebral Amyloid Angiopathy Pathology and Its Association With Amyloid-β PET Signal 2021
• Disentangling the Gordian Knot: The birth, father, and future of balloon embolization 2021
• Is having multiple sclerosis associated with reproductive milestones in women? 2021
• Longitudinal Accumulation of Cerebral Microhemorrhages in Dominantly Inherited Alzheimer Disease 2021
• Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration 2021
• Temporal onset of core features in Lewy body disease pathologic subtypes 2021
• The Value of Multimodal Imaging with 123I-FP-CIT SPECT in Differential Diagnosis of Dementia with Lewy Bodies and Alzheimer's Disease Dementia 2021
• β-Amyloid PET and ¹²³I-FP-CIT SPECT in Mild Cognitive Impairment at Risk for Lewy Body Dementia 2021
• Adipose-derived Mesenchymal Stem Cells Ameliorate Neuroinflammation and promote neurogenesis in a Transgenic Mouse Model of Huntington's disease 2020
• Age of Onset of Cognitive Impairment and the Core Features of Dementia with Lewy Bodies 2020
• Association of common genetic variants with brain microbleeds A genome-wide association study 2020
• Cerebral microbleed incidence, relationship to amyloid burden: The Mayo Clinic Study of Aging 2020
• Clinical and Pathologic Features of Patients with REM Sleep Behavior Disorder and Parkinsonism in the Mild Cognitive Impairment Stage of Lewy Body Disease 2020
• Nulliparity is associated with earlier evolution of progressive multiple sclerosis in women 2020
• REM sleep atonia loss distinguishes synucleinopathy in older adults with cognitive impairment 2020
• Research criteria for the diagnosis of prodromal dementia with Lewy bodies 2020
• Revised Self-Monitoring Scale A potential endpoint for frontotemporal dementia clinical trials 2020
• Subtypes of dementia with Lewy bodies are associated with α-synuclein and tau distribution 2020
• The ARTFL LEFFTDS Frontotemporal Lobar Degeneration (ALLFTD) Protocol: Preliminary Data and Future Plans 2020
• β-Amyloid PET and neuropathology in dementia with Lewy bodies 2020
• β-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodies 2020
• APOE and cortical superficial siderosis in CAA Meta-analysis and potential mechanisms 2019
• Cardiovascular and metabolic risk factors for the development of cerebral small vessel disease: Longitudinal FLAIR imaging in the Mayo Clinic Study of Aging 2019
• Cerebral microbleeds: Prevalence and relationship to amyloid burden 2019
• Cerebrospinal fluid dynamics disorders Relationship to Alzheimer biomarkers and cognition 2019
• Characteristics and Progress on 369 Subjects in the Longitudinal Evaluation Familial Frontotemporal Dementia Subjects (LEFFTDS) Protocol 2019
• Cross-sectional associations of tau-PET signal with cognition in cognitively unimpaired adults 2019
• Development of ¹H MRS biomarkers for tracking early predementia Alzheimer disease 2019
• Different Rates of Lobar Atrophy Between Symptomatic and Asymptomatic MAPT Mutation Carriers 2019
• Frontal lobe ¹H MR spectroscopy in asymptomatic and symptomatic MAPT mutation carriers 2019
• Progress and Participant Characterization in the Advancing Research and Treatment in Frontotemporal Lobar Degeneration (ARTFL) Rare Disease Clinical Research Consortium 2019
• Prominent Auditory Hallucinations in Behavioral Variant Frontotemporal Dementia Associated with a MAPT Mutation 2019
• Reciprocal regulation of filamin A and amyloid precursor protein expression in astrocytes 2019
• Bagel Sign in neuro-Behcet's Syndrome 2018
• Brain structure and cognition 3 years after the end of an early menopausal hormone therapy trial 2018
• Characteristics and Progress on 312 Subjects in the Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects (LEFFTDS) Protocol 2018
• Diagnostic Yield of REM Sleep Muscle Activity for Presumed Synucleinopathy Neurodegeneration 2018
• In vivo ¹⁸F-AV-1451 tau PET signal in MAPT mutation carriers varies by expected tau isoforms 2018
• MRI-derived markers of disease progression in early versus late PSP and CBS 2018
• Sex differences in cerebrovascular pathologies on FLAIR in cognitively unimpaired elderly 2018
• The Advancing Research and Treatment in Frontotemporal Lobar Degeneration (ARTFL) North American Rare Disease Clinical Research Consortium: Progress and Participant Characterization 2018
• ¹H-MRS metabolites and rate of β-amyloid accumulation on serial PET in clinically normal adults 2017
• Advanced 1H-MRS detects decreased glutamate levels in amnestic MCI 2017
• Brain tissue metabolites on baseline MRS are associated with greater β-amyloid accumulation rate from serial PET in clinically normal older adults 2017
• Characteristics and Progress on the Initial 209 Subjects in the Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects (LEFFTDS) Protocol 2017
• Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium 2017
• Pittsburgh compound-B PET and MRI biomarkers of cognition in aging MS patients 2017
• Targeting sphingosine-1-phosphate lyase is neuroprotective in a neuron model of Huntington's disease 2017
• The Advancing Research and Treatment in Frontotemporal Lobar Degeneration (ARTFL) North American Rare Disease Clinical Research Consortium: Progress and Characterization of Initial Participants 2017
• AD-Related Pathology and Gray Matter Atrophy Rates in Probable Dementia with Lewy Bodies 2016
• Age and neurodegeneration imaging biomarkers in persons with Alzheimer disease dementia 2016
• An Investigation of White Matter Hyperintensities in Probable Dementia with Lewy Bodies 2016
• An MRI Atlas for Imaging and Pathologic Correlation Studies in Alzheimer's Disease 2016
• Clinical-Imaging-Pathologic Analysis in Seven Patients with Dementia: Correlations with Ioflupane SPECT Findings 2016
• Cognition and Brain Atrophy Decades after Hypertensive Pregnancy Disorders 2016
• Effects of hormone therapy on brain structure A randomized controlled trial 2016
• Hippocampal volumes predict risk of dementia with Lewy bodies in mild cognitive impairment 2016
• MR spectroscopy, APOE genotype, and evolving β-amyloid pathology What is being detected and when 2016
• Neuropsychological and MRI Findings in MAPT Mutation Carriers in the Evolution from the Asymptomatic to Symptomatic State 2016
• Antemortem MRI findings associated with microinfarcts at autopsy 2014
• Association of hypometabolism and amyloid levels in aging, normal subjects 2014
• Association of type 2 diabetes with brain atrophy and cognitive impairment 2014
• Dementia with Lewy bodies Basis of cingulate island sign 2014
• LESIONAL REM SLEEP BEHAVIOR DISORDER LOCALIZES TO THE DORSOMEDIAL PONS 2014
• Past hormone therapy in older women Does the brain recover from adverse effects? 2014
• Spontaneous amyloid-related imaging abnormalities in a cognitively normal adult 2014
• Acceleration of Brain Injury Biomarker Abnormalities in Cognitively Normal Elderly with β-Amyloidosis 2013
• Acceleration of Brain Injury Biomarker Abnormalities in Cognitively Normal Elderly with β-Amyloidosis 2013
• Antemortem MRI Findings Associated with Microinfarcts at Autopsy 2013
• DaTscan Findings in Patients with Mild Cognitive Impairment, Alzheimer's Disease and Dementia with Lewy Bodies 2013
• DaTscan Findings in Patients with Mild Cognitive Impairment, Alzheimer's Disease and Dementia with Lewy Bodies 2013
• Diabetes Is Associated with Global and Regional Hypometabolism among Elderly Persons: The Mayo Clinic Study of Aging 2013
• MRI and MRS predictors of mild cognitive impairment in a population-based sample 2013
• MRI and pathology of REM sleep behavior disorder in dementia with Lewy bodies 2013
• Non-Amnestic Mild Cognitive Impairment Progresses to Dementia with Lewy Bodies 2013
• Nonamnestic mild cognitive impairment progresses to dementia with Lewy bodies 2013
• REM Sleep Behavior Disorder Is Associated with Reduced Alzheimer's Pathology, Hippocampal and Parietotemporal Atrophy in Dementia with Lewy Bodies 2013
• Thrombogenic microvesicles and white matter hyperintensities in postmenopausal women 2013
• White Matter Hyperintensities in Recently Menopausal Women Are Associated with Platelet-Derived Surrogate Markers of Cardiovascular Risk 2013
• White Matter Hyperintensities in Recently Menopausal Women Are Associated with Platelet-Derived Surrogate Markers of Cardiovascular Risk 2013
• APOE modifies the association between Aβ load and cognition in cognitively normal older adults 2012
• Characterization of Frontotemporal Dementia +/- Amyotrophic Lateral Sclerosis Associated with the GGGGCC Repeat Expansion in C9ORF72 2012
• Focal atrophy on MRI and neuropathologic classification of dementia with Lewy bodies 2012
• Focal atrophy on MRI and neuropathologic classification of dementia with Lewy bodies (vol 79, pg 553, 2012) 2012
• Imaging markers offer promise Dream enactment may predict your patient's future 2012
• RBD Is Associated with Reduced Alzheimer's Pathology in Dementia with Lewy Bodies 2012
• Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease 2012
• Similar clinical and neuroimaging features in monozygotic twin pair with mutation in progranulin 2012
• Antemortem Hippocampal Atrophy Predicts Presence of Alzheimer's Disease Pathology in Pathologically Proven Lewy Body Disease 2011
• Diabetes Mellitus and FDG PET Imaging in Non-Demented Elderly 2011
• Diffusion tensor imaging and cognitive function in older adults with no dementia 2011
• Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies 2011
• Magnetic resonance spectroscopy, β-amyloid load, and cognition in a population-based sample of cognitively normal older adults 2011
• β-Amyloid Deposition, ¹H MRS Metabolites and Cognitive Function in a Population-Based Cohort of Cognitively Normal Elderly 2011
• Dementia with Lewy bodies and Alzheimer disease Neurodegenerative patterns characterized by DTI 2010
• Gray and white matter water diffusion in the syndromic variants of frontotemporal dementia 2010
• MRS in presymptomatic MAPT mutation carriers A potential biomarker for tau-mediated pathology 2010
• Aberrant Tau Pathology Underlies ¹H MR Spectroscopic Alterations in Alzheimer's Disease 2009
• Diabetes Mellitus Severity Is Associated with Subcortical Infarctions on MRI: The Mayo Clinic Study of Aging 2009
• Diffusion Tensor Imaging Characteristics of Dementia with Lewy bodies and Alzheimer's Disease 2009
• Measurement of Grey Matter Water Diffusion in Frontotemporal Dementia Variants and Alzheimer's Disease 2009
• Risk of dementia in MCI Combined effect of cerebrovascular disease, volumetric MRI, and ¹H MRS 2009
• A voxel-based morphometry study correlating MRI with neurofibrillary tangle pathology at autopsy 2008
• Antemortem MRI based structural abnormality index (STAND)-scores correlate with postmortem Braak stages 2008
• Hippocampal atrophy, cortical infarctions and decreased NAA/Cr have additive effects on the risk of progression to dementia in MCI 2008
• MRI correlates of neurofibrillary tangle pathology at autopsy - A voxel-based morphometry study 2008
• Neuropathological correlates of antemortem ¹H MR Spectroscopy in Alzheimer disease 2008
• ¹H MR spectroscopy markers of cardiovascular risk factors in non-demented eldergy 2007
• DTI measures of hippocampal diffusivity differ between amnestic and non-amnestic MCI 2007
• Analysis of plasma amyloid beta in posterior cortical atrophy (PCA) 2006
• Longitudinal change in ¹H MR spectroscopy metabolites in mild cognitive impairment and Alzheimer's disease 2006
• Patterns of atrophy on MRI in dementia with Lewy Bodies and Alzheimer's disease: A voxel-based morphometry study 2006
• Regional grey matter loss in specific subtypes in mild cognitive impairment 2006
• ¹H MR spectroscopy findings differ among mild cognitive impairment syndromes 2005
• DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment 2005
• ¹H MR spectroscopy in common dementias 2004
• Annual decrease in N-acetylaspartate/creatine correlates with the progression of Alzheimer's disease 2004
• DWI predicts future progression to Alzheimer's disease in people with amnestic mild cognitive impairment 2004
• Comparative diagnostic utility of ¹H MRS and DWI in evaluation of temporal lobe epilepsy 2002
• Lateralized and focal clinical, EEG, and MRI FLAIR sequence abnormalities in Creutzfeldt-Jakob Disease 2000
• Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease - A ¹H MRS study 2000